Nea 15 Gp, Llc - Net Worth and Insider Trading

Nea 15 Gp, Llc Net Worth

The estimated net worth of Nea 15 Gp, Llc is at least $46 Million dollars as of 2024-05-05. Nea 15 Gp, Llc is the 10% Owner of Ardelyx Inc and owns about 5,331,039 shares of Ardelyx Inc (ARDX) stock worth over $46 Million. Details can be seen in Nea 15 Gp, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nea 15 Gp, Llc has not made any transactions after 2016-07-18 and currently still holds the listed stock(s).

Transaction Summary of Nea 15 Gp, Llc

Nea 15 Gp, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nea 15 Gp, Llc owns 21 companies in total, including Eargo Inc (EAR) , Inozyme Pharma Inc (INZY) , and Annexon Inc (ANNX) among others .

Click here to see the complete history of Nea 15 Gp, Llc’s form 4 insider trades.

Insider Ownership Summary of Nea 15 Gp, Llc

Ticker	Comapny	Transaction Date	Type of Owner
EAR	Eargo Inc	2020-10-15	10 percent owner
INZY	Inozyme Pharma Inc	2020-07-23	10 percent owner
ANNX	Annexon Inc	2020-07-23	10 percent owner
		2020-07-09	10 percent owner
		2016-05-13	10 percent owner
		2016-07-18	10 percent owner
		2019-06-07	10 percent owner
		2018-12-07	10 percent owner
		2018-03-09	10 percent owner
		2015-06-16	10 percent owner
		2016-12-19	10 percent owner
		2018-12-07	10 percent owner
		2021-04-08	10 percent owner
		2021-06-24	10 percent owner
		2020-12-09	10 percent owner
		2021-07-29	director & 10 percent owner
		2022-02-03	10 percent owner
		2021-07-21	10 percent owner
		2021-09-30	10 percent owner
		2022-06-08	10 percent owner
		2021-07-21	10 percent owner

Nea 15 Gp, Llc Latest Holdings Summary

Nea 15 Gp, Llc currently owns a total of 1 stock. Nea 15 Gp, Llc owns 5,331,039 shares of Ardelyx Inc (ARDX) as of July 18, 2016, with a value of $46 Million.

Latest Holdings of Nea 15 Gp, Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ARDX	Ardelyx Inc	2016-07-18	5,331,039	8.72	46,486,660

Holding Weightings of Nea 15 Gp, Llc

Nea 15 Gp, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Nea 15 Gp, Llc has made a total of 0 transactions in Ardelyx Inc (ARDX) over the past 5 years. The most-recent trade in Ardelyx Inc is the acquisition of 1,527,301 shares on July 18, 2016, which cost Nea 15 Gp, Llc around $13 Million.

Insider Trading History of Nea 15 Gp, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nea 15 Gp, Llc Trading Performance

GuruFocus tracks the stock performance after each of Nea 15 Gp, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nea 15 Gp, Llc is 7.47%. GuruFocus also compares Nea 15 Gp, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nea 15 Gp, Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nea 15 Gp, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nea 15 Gp, Llc

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	4.14
Relative Return to S&P 500(%)	4.35

Nea 15 Gp, Llc Ownership Network

Ownership Network List of Nea 15 Gp, Llc

No Data

Ownership Network Relation of Nea 15 Gp, Llc

Nea 15 Gp, Llc Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Nea 15 Gp, Llc is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eargo Inc Insider Transactions

No Available Data

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Nea 15 Gp, Llc is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .

Inozyme Pharma Inc (INZY) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inozyme Pharma Inc Insider Transactions

No Available Data

What does Annexon Inc do?

Who are the key executives at Annexon Inc?

Nea 15 Gp, Llc is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Financial Officer Jennifer Lew , EVP & Chief Innovation Officer Ted Yednock , and EVP & Chief Business Officer Michael Overdorf .

Annexon Inc (ANNX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 47,471 shares made by Ted Yednock , a net sale of 7,367 shares made by Jennifer Lew , and a net sale of 5,923 shares made by Michael Overdorf .

In summary, during the past 3 months, insiders sold 17,898 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 11,498 shares. During the past 18 months, 73,114 shares of Annexon Inc (ANNX) were sold and 3,303,458 shares were bought by its insiders, resulting in a net purchase of 3,230,344 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Annexon Inc Insider Transactions

No Available Data

What does Nkarta Inc do?

Who are the key executives at Nkarta Inc?

Nea 15 Gp, Llc is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include 10 percent owner Ra Capital Healthcare Fund Lp , Chief Scientific Officer James Trager , and Chief Medical Officer David Shook .

Nkarta Inc (NKTX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nkarta Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Nea 15 Gp, Llc is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Nea 15 Gp, Llc is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , See Remarks Elizabeth A Grammer , and Chief Development Officer David P. Rosenbaum .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 129,101 shares made by David P. Rosenbaum , a net sale of 115,747 shares made by Michael Raab , and a net sale of 151,748 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 204,646 shares of Ardelyx Inc (ARDX) in total and bought 0 shares, with a net sale of 204,646 shares. During the past 18 months, 792,466 shares of Ardelyx Inc (ARDX) were sold and 567,000 shares were bought by its insiders, resulting in a net sale of 225,466 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Nightstar Therapeutics PLC do?

Who are the key executives at Nightstar Therapeutics PLC?

Nea 15 Gp, Llc is the 10 percent owner of Nightstar Therapeutics PLC. Other key executives at Nightstar Therapeutics PLC include 10 percent owner Scott D Sandell , 10 percent owner Peter J Barris , and director & 10 percent owner David M Mott .

Nightstar Therapeutics PLC (NITE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nightstar Therapeutics PLC (NITE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nightstar Therapeutics PLC (NITE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nightstar Therapeutics PLC (NITE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nightstar Therapeutics PLC Insider Transactions

No Available Data

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Nea 15 Gp, Llc is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does Cascadian Therapeutics Inc do?

Who are the key executives at Cascadian Therapeutics Inc?

Nea 15 Gp, Llc is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner Florence Anthony A. Jr. , and 10 percent owner Peter W. Sonsini .

Cascadian Therapeutics Inc (CASC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cascadian Therapeutics Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Nea 15 Gp, Llc is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Nea 15 Gp, Llc is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Nea 15 Gp, Llc is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include Corporate Controller Justin Trojanowski , VP of Strategy and Finance Nicholas Maestas , and director & 10 percent owner Thomas Woiwode .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tempest Therapeutics Inc (TPST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

What does Reneo Pharmaceuticals Inc do?

Who are the key executives at Reneo Pharmaceuticals Inc?

Nea 15 Gp, Llc is the 10 percent owner of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .

Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 125,000 shares made by Niall O'donnell , a net sale of 100,000 shares made by Novo Holdings A/s , and a net sale of 15,625 shares made by Ashley Hall .

In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 115,625 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 125,000 shares were bought by its insiders, resulting in a net purchase of 9,375 shares.

Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reneo Pharmaceuticals Inc Insider Transactions

No Available Data

What does NeueHealth Inc do?

Who are the key executives at NeueHealth Inc?

Nea 15 Gp, Llc is the 10 percent owner of NeueHealth Inc. Other key executives at NeueHealth Inc include Chief Financial Officer Jay Matushak , director & CEO and President Mikan George Lawrence Iii , and GC & CORPORATE SECRETARY Jeff Michael Craig .

NeueHealth Inc (NEUE) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 451,635 shares made by Mikan George Lawrence Iii , a net sale of 51,710 shares made by Jeffrey J Scherman , and a net sale of 21,838 shares made by Jeff Michael Craig .

In summary, during the past 3 months, insiders sold 38,712 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 38,712 shares. During the past 18 months, 645,101 shares of NeueHealth Inc (NEUE) were sold and 1,185,000 shares were bought by its insiders, resulting in a net purchase of 539,899 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeueHealth Inc Insider Transactions

No Available Data

What does Desktop Metal Inc do?

Who are the key executives at Desktop Metal Inc?

Nea 15 Gp, Llc is the 10 percent owner of Desktop Metal Inc. Other key executives at Desktop Metal Inc include 10 percent owner Farhad Fred Ebrahimi , CFO & TREASURER Jason M Cole , and director & Chief Executive Officer Ric Fulop .

Desktop Metal Inc (DM) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Desktop Metal Inc (DM). Other recent insider transactions involving Desktop Metal Inc (DM) include a net sale of 26,969 shares made by Scott J Dussault ,

In summary, during the past 3 months, insiders sold 0 shares of Desktop Metal Inc (DM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,969 shares of Desktop Metal Inc (DM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,969 shares.

Desktop Metal Inc (DM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Desktop Metal Inc Insider Transactions

No Available Data

What does Robinhood Markets Inc do?

Who are the key executives at Robinhood Markets Inc?

Nea 15 Gp, Llc is the director & 10 percent owner of Robinhood Markets Inc. Other key executives at Robinhood Markets Inc include director & 10 percent owner & Chief Executive Officer Vladimir Tenev , Chief Financial Officer Jason Warnick , and director & 10 percent owner & Chief Creative Officer Baiju Bhatt .

Robinhood Markets Inc (HOOD) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Robinhood Markets Inc (HOOD). Other recent insider transactions involving Robinhood Markets Inc (HOOD) include a net sale of 2,691,989 shares made by Baiju Bhatt , a net sale of 2,897,302 shares made by Vladimir Tenev , and a net sale of 265,021 shares made by Gallagher Daniel Martin Jr .

In summary, during the past 3 months, insiders sold 2,150,526 shares of Robinhood Markets Inc (HOOD) in total and bought 0 shares, with a net sale of 2,150,526 shares. During the past 18 months, 6,005,207 shares of Robinhood Markets Inc (HOOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,005,207 shares.

Robinhood Markets Inc (HOOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Robinhood Markets Inc Insider Transactions

No Available Data

What does Arcellx Inc do?

Who are the key executives at Arcellx Inc?

Nea 15 Gp, Llc is the 10 percent owner of Arcellx Inc. Other key executives at Arcellx Inc include Chief Medical Officer Christopher Heery , director & See Remarks Rami Elghandour , and Chief Financial Officer Michelle Gilson .

Arcellx Inc (ACLX) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 283,452 shares made by Christopher Heery , a net sale of 124,266 shares made by Rami Elghandour , and a net sale of 1,987,663 shares made by Jill Carroll .

In summary, during the past 3 months, insiders sold 665,735 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 665,735 shares. During the past 18 months, 3,459,214 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,459,214 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcellx Inc Insider Transactions

No Available Data

What does Berkshire Grey Inc do?

Who are the key executives at Berkshire Grey Inc?

Nea 15 Gp, Llc is the 10 percent owner of Berkshire Grey Inc. Other key executives at Berkshire Grey Inc include 10 percent owner Svf Ii Bg (de) Llc , 10 percent owner Softbank Group Corp , and director & Chief Executive Officer Thomas Anderson Wagner .

Berkshire Grey Inc (BGRY) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in Berkshire Grey Inc (BGRY). Other recent insider transactions involving Berkshire Grey Inc (BGRY) include a net sale of 65,567,317 shares made by Svf Ii Bg (de) Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Berkshire Grey Inc (BGRY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 65,567,317 shares of Berkshire Grey Inc (BGRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,567,317 shares.

Berkshire Grey Inc (BGRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Berkshire Grey Inc Insider Transactions

No Available Data

What does IonQ Inc do?

Who are the key executives at IonQ Inc?

Nea 15 Gp, Llc is the 10 percent owner of IonQ Inc. Other key executives at IonQ Inc include Chief Revenue Officer Rima Alameddine , director & President and CEO Peter Hume Chapman , and director & Chief Strategy Officer Jungsang Kim .

IonQ Inc (IONQ) Insider Trades Summary

Over the past 18 months, Nea 15 Gp, Llc made no insider transaction in IonQ Inc (IONQ). Other recent insider transactions involving IonQ Inc (IONQ) include a net sale of 104,634 shares made by Peter Hume Chapman , a net sale of 55,864 shares made by Thomas G. Kramer , and a net sale of 42,076 shares made by Jungsang Kim .

In summary, during the past 3 months, insiders sold 86,556 shares of IonQ Inc (IONQ) in total and bought 115,000 shares, with a net purchase of 28,444 shares. During the past 18 months, 720,604 shares of IonQ Inc (IONQ) were sold and 115,000 shares were bought by its insiders, resulting in a net sale of 605,604 shares.

IonQ Inc (IONQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

IonQ Inc Insider Transactions

No Available Data

What does Senti Biosciences Inc do?

Who are the key executives at Senti Biosciences Inc?

Nea 15 Gp, Llc is the 10 percent owner of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include Chief Medical & Devt. Officer Kanya Rajangam , Chief Operating Officer Herberts Curt A. Iii , and 10 percent owner Bayer Us Holding Lp .

Senti Biosciences Inc (SNTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senti Biosciences Inc Insider Transactions

No Available Data

What does Revolution Acceleration Acquisition Corp do?

Who are the key executives at Revolution Acceleration Acquisition Corp?

Nea 15 Gp, Llc is the 10 percent owner of Revolution Acceleration Acquisition Corp. Other key executives at Revolution Acceleration Acquisition Corp include 10 percent owner Softbank Group Corp , director & Chief Executive Officer Thomas Anderson Wagner , and See Remarks Steven Jay Johnson .

Revolution Acceleration Acquisition Corp (RAACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Acceleration Acquisition Corp (RAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Acceleration Acquisition Corp (RAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Acceleration Acquisition Corp (RAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Acceleration Acquisition Corp Insider Transactions

No Available Data

Nea 15 Gp, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Nea 15 Gp, Llc. You might contact Nea 15 Gp, Llc via mailing address: 1954 Greenspring Drive, Suite 600, Timonium Md 21093.

Discussions on Nea 15 Gp, Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.